Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 134th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
XERS	XERIS BIOPHARMA HOLDINGS INC	$3.04B	-39.50%	-1.60%	7.25%	7.10%	7.68	2.15	87.40%	-1.80%	5.69%
REGN	REGENERON PHARMACEUTICALS INC	$98.84B	15.10%	11.50%	15.01%	16.40%	0.33	3.35	85.80%	28.50%	33.93%
FENC	FENNEC PHARMACEUTICALS INC	$410.25M	4.90%	2.70%	4.02%	12.70%	0.70	6.11	94.10%	3.10%	4.26%
ONC	BEONE MEDICINES LTD	$47.63B	18.20%	10.20%	17.23%	33.90%	0.70	3.55	89.40%	13.90%	19.93%
CORT	CORCEPT THERAPEUTICS INC	$7.98B	22.60%	17.80%	12.61%	17.10%	0.24	3.01	98.50%	16.50%	11.20%
EXEL	EXELIXIS INC	$16.84B	45.50%	33.90%	50.72%	53.20%	0.37	3.21	96.30%	35.50%	42.69%
PHAR	PHARMING GROUP NV	$891.80M	8.70%	5.00%	8.65%	14.80%	0.71	3.23	85.10%	6.30%	8.88%
VCEL	VERICEL CORP	$2.91B	9.10%	6.70%	7.53%	8.30%	0.35	5.13	74.50%	10.30%	10.74%
PGEN	PRECIGEN INC	$1.63B	57.90%	14.40%	20.09%	18.00%	1.53	5.58	91.40%	15.60%	23.21%
RPRX	ROYALTY PHARMA PLC	$39.76B	6.80%	3.40%	5.71%	4.00%	0.99	1.29	100.00%	25.70%	39.88%
HALO	HALOZYME THERAPEUTICS INC	$11.43B	544.30%	17.30%	22.59%	22.80%	-63.88	3.88	82.30%	26.90%	37.56%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$7.57B	17.30%	12.60%	18.47%	26.90%	0.38	3.91	90.20%	11.60%	15.45%
ALEC	ALECTOR INC	$378.15M	112.20%	18.40%	32.04%	29.80%	0.42	4.10	100.00%	23.90%	24.08%
PTGX	PROTAGONIST THERAPEUTICS INC	$8.55B	42.80%	40.30%	32.10%	69.30%	0.06	19.85	99.80%	62.00%	63.49%
PLX	PROTALIX BIOTHERAPEUTICS INC	$257.17M	30.70%	19.90%	30.61%	47.90%	0.47	3.27	71.20%	24.30%	31.81%
ASND	ASCENDIS PHARMA A	$18.06B	107.50%	43.70%	22.58%	35.70%	0.62	2.89	91.90%	72.90%	35.25%
BMRN	BIOMARIN PHARMACEUTICAL INC	$11.09B	-0.30%	-0.20%	1.81%	2.60%	0.85	2.44	76.00%	-0.50%	4.93%
NRIX	NURIX THERAPEUTICS INC	$1.69B	49.30%	38.60%	28.95%	68.40%	0.23	8.44	100.00%	42.00%	43.91%
NVAX	NOVAVAX INC	$1.41B	N/A	-7.60%	-8.98%	-8.40%	-5.10	2.15	78.00%	-18.60%	-12.17%
ZVRA	ZEVRA THERAPEUTICS INC	$540.30M	38.20%	26.50%	34.40%	62.20%	0.31	5.46	95.40%	52.80%	63.37%
PBYI	PUMA BIOTECHNOLOGY INC	$401.70M	17.50%	11.80%	19.98%	38.00%	0.38	3.03	73.60%	10.30%	13.00%
OMER	OMEROS CORP	$1.27B	-109.40%	46.00%	70.76%	25.50%	-6.59	1.95	96.40%	324.90%	353.38%
MDGL	MADRIGAL PHARMACEUTICALS INC	$9.93B	-27.10%	-12.00%	-12.58%	-12.90%	1.29	3.05	91.00%	-10.90%	-8.64%
TGTX	TG THERAPEUTICS INC	$9.75B	17.60%	7.30%	14.73%	13.00%	1.78	4.50	82.70%	11.80%	21.85%
FTRE	FORTREA HOLDINGS INC	$1.95B	-12.80%	-2.50%	1.66%	2.50%	4.14	0.97	20.00%	-2.60%	1.09%
XNCR	XENCOR INC	$2.78B	-21.30%	-15.20%	-13.26%	-11.30%	0.38	6.54	100.00%	-58.80%	-45.91%
LEGN	LEGEND BIOTECH CORP	$3.39B	0.00%	0.00%	3.79%	8.20%	0.32	3.95	57.00%	0.00%	3.89%
EWTX	EDGEWISE THERAPEUTICS INC	$5.03B	130.40%	121.20%	71.21%	161.40%	0.09	12.30	N/A	N/A	N/A
ZYME	ZYMEWORKS INC	$1.81B	22.50%	7.20%	5.47%	10.30%	3.56	3.30	100.00%	16.30%	20.86%
ANL	ADLAI NORTYE GROUP LTD	$682.58M	-20.20%	-14.10%	-9.53%	-39.60%	0.16	9.55	100.00%	-124.80%	-117.79%
KRYS	KRYSTAL BIOTECH INC	$9.05B	17.00%	15.50%	17.92%	29.70%	0.11	7.89	94.30%	47.90%	55.06%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$1.96B	-31.90%	-9.80%	-7.92%	-9.60%	1.33	4.66	39.10%	-30.80%	-21.09%
ACAD	ACADIA PHARMACEUTICALS INC	$3.24B	28.00%	21.60%	10.75%	15.80%	0.29	3.82	90.50%	30.10%	13.08%
JAZZ	JAZZ PHARMACEUTICALS PLC	$15.50B	4.60%	1.80%	4.52%	6.30%	1.86	1.82	89.10%	4.40%	9.06%
ACIU	AC IMMUNE SA	$216.71M	-104.10%	-24.80%	-86.22%	177.30%	4.17	0.85	100.00%	-181.90%	-180.80%
IOVA	IOVANCE BIOTHERAPEUTICS INC	$3.59B	-29.70%	-23.60%	-25.05%	-48.50%	0.22	5.20	53.20%	-58.20%	-58.52%
GERN	GERON CORP	$624.91M	-21.30%	-8.90%	-4.20%	-3.00%	1.33	6.31	91.60%	-22.00%	-8.75%
GMAB	GENMAB A	$32.06B	12.20%	5.80%	10.83%	21.80%	1.04	2.45	92.60%	17.00%	29.33%
ADMA	ADMA BIOLOGICS INC	$3.03B	42.60%	27.00%	38.47%	38.40%	0.67	6.04	68.50%	35.10%	47.22%
HOWL	WEREWOLF THERAPEUTICS INC	$47.63M	-167.00%	-59.90%	-184.51%	-237.20%	0.48	2.91	100.00%	-164.80%	-143.14%
ABUS	ARBUTUS BIOPHARMA CORP	$626.97M	129.10%	89.30%	225.00%	210.00%	2.96	1.40	100.00%	121.20%	121.21%
AUPH	AURINIA PHARMACEUTICALS INC	$2.11B	51.90%	40.60%	23.43%	26.10%	0.26	6.12	90.60%	97.70%	53.15%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$3.57B	14.20%	6.30%	12.65%	11.60%	1.15	2.92	91.20%	5.90%	8.76%
FHTX	FOGHORN THERAPEUTICS INC	$124.12M	-13.50%	4.60%	6.13%	8.50%	-14.56	4.24	100.00%	8.40%	8.40%
NVO	NOVO NORDISK A S	$183.56B	54.10%	19.70%	41.37%	44.90%	1.75	0.85	80.80%	33.90%	43.36%
ROIV	ROIVANT SCIENCES LTD	$28.64B	-8.10%	-6.50%	-5.11%	-6.50%	0.10	15.56	88.70%	-838.20%	-584.19%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$1.98B	18.50%	13.20%	20.38%	45.00%	0.38	3.44	74.00%	18.10%	24.85%
APMD	APNIMED INC	$704.39M	N/A	N/A	N/A	N/A	-0.71	5.19	N/A	N/A	N/A
ARMP	ARMATA PHARMACEUTICALS INC	$143.94M	N/A	-153.10%	84.12%	-34.20%	-1.49	0.12	100.00%	-1,626.30%	-1,139.09%
BCRX	BIOCRYST PHARMACEUTICALS INC	$1.96B	N/A	-67.60%	-70.32%	-29.10%	-2.49	2.71	97.90%	-37.40%	-28.90%
PRLD	PRELUDE THERAPEUTICS INC	$275.32M	-75.40%	-44.40%	-39.97%	-75.30%	0.42	4.07	100.00%	-269.70%	-269.75%
OABI	OMNIAB INC	$716.17M	-16.70%	-14.80%	-16.01%	-62.90%	0.17	4.21	97.70%	-108.10%	-109.12%
TVTX	TRAVERE THERAPEUTICS INC	$4.86B	-186.50%	-17.30%	-18.50%	-15.10%	36.56	3.00	98.50%	-18.70%	-18.12%
KROS	KEROS THERAPEUTICS INC	$202.13M	-21.80%	-19.80%	-21.43%	-159.90%	0.10	18.14	100.00%	-151.40%	-153.25%
PTCT	PTC THERAPEUTICS INC	$5.30B	N/A	-3.50%	4.67%	8.10%	-17.78	3.27	93.20%	-9.20%	9.82%
AVXL	ANAVEX LIFE SCIENCES CORP	$86.49M	-12.80%	-11.70%	-11.56%	161.70%	0.07	15.62	N/A	N/A	N/A
AXSM	AXSOME THERAPEUTICS INC	$7.45B	-189.70%	-21.00%	-47.63%	-98.90%	6.84	1.42	93.20%	-18.20%	-17.45%
KZIA	KAZIA THERAPEUTICS LTD	$375.22M	-217.80%	-51.20%	-52.23%	207.80%	0.53	2.87	100.00%	-1,200.90%	-1,285.72%
RIGL	RIGEL PHARMACEUTICALS INC	$837.18M	73.90%	59.60%	17.87%	22.10%	0.18	2.39	89.60%	106.60%	27.60%
SRPT	SAREPTA THERAPEUTICS INC	$1.72B	1.00%	0.50%	1.49%	1.20%	1.07	3.46	56.80%	0.80%	1.91%
PYPD	POLYPID LTD	$127.15M	-243.60%	-119.00%	-366.05%	-332.50%	1.83	1.35	N/A	N/A	N/A
URGN	UROGEN PHARMA LTD	$1.28B	N/A	-26.90%	-23.49%	-17.40%	-3.17	3.40	91.40%	-26.30%	-18.57%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$4.70B	-37.40%	-12.00%	-10.53%	-10.50%	2.83	3.97	74.20%	-23.70%	-20.63%
AGEN	AGENUS INC	$304.51M	-14.80%	14.20%	218.08%	70.30%	-3.40	0.73	100.00%	22.00%	68.15%
LITS	LITE STRATEGY INC	$25.40M	-86.90%	-85.20%	-90.82%	-97.70%	0.03	3.64	N/A	N/A	N/A
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$240.96M	-46.80%	-36.50%	-46.66%	-422.30%	0.28	6.68	100.00%	-285.90%	-285.93%
BOLD	BOUNDLESS BIO INC	$59.03M	-71.00%	-51.00%	-89.91%	-54.20%	0.03	33.97	N/A	N/A	N/A
INDP	INDAPTUS THERAPEUTICS INC	$486.92M	-206.80%	-98.70%	-130.63%	299.00%	2.02	1.50	N/A	N/A	N/A
ORMP	ORAMED PHARMACEUTICALS INC	$161.33M	52.90%	45.60%	13.66%	19.10%	0.18	6.07	N/A	N/A	N/A
NAMS	NEWAMSTERDAM PHARMA CO NV	$2.42B	-31.40%	-28.30%	-32.29%	-100.60%	0.09	11.76	100.00%	-789.90%	-785.29%
DNTH	DIANTHUS THERAPEUTICS INC	$5.17B	-19.70%	-18.90%	-16.20%	-24.50%	0.03	30.02	100.00%	-7,436.50%	-7,436.50%
ARGX	ARGENX SE	$60.04B	23.60%	19.90%	20.69%	41.10%	0.19	5.12	90.10%	32.20%	32.85%
INSM	INSMED INC	$26.58B	-82.70%	-27.90%	-31.71%	-30.50%	2.07	2.86	84.40%	-39.90%	-34.00%
MRNA	MODERNA INC	$90.38B	-37.60%	-23.10%	-23.85%	-27.40%	0.97	3.62	28.00%	-110.50%	-108.08%
ATRA	ATARA BIOTHERAPEUTICS INC	$78.45M	N/A	-73.20%	-111.14%	-23.90%	-1.49	1.72	82.70%	-368.60%	-337.45%
HYPD	HYPERION DEFI INC	$40.09M	5.20%	4.40%	26.24%	37.10%	0.11	2.34	78.40%	252.00%	2,016.22%
RYTM	RHYTHM PHARMACEUTICALS INC	$7.97B	-175.10%	-44.00%	-59.54%	-64.60%	2.75	2.78	88.20%	-70.60%	-61.98%
VCYT	VERACYTE INC	$1.96B	9.30%	8.60%	7.94%	44.30%	0.10	5.56	72.00%	21.80%	20.33%
VIR	VIR BIOTECHNOLOGY INC	$1.71B	-21.40%	-17.00%	-17.91%	-22.80%	0.24	6.30	100.00%	-61.00%	-61.00%
ARDX	ARDELYX INC	$776.74M	-35.30%	-10.20%	-7.19%	-5.50%	2.58	3.45	94.50%	-11.80%	-7.06%
GLUE	MONTE ROSA THERAPEUTICS INC	$800.67M	-30.10%	-20.40%	-20.44%	-25.70%	0.41	10.32	100.00%	-186.20%	-184.77%
RNA	ATRIUM THERAPEUTICS INC	$162.00M	-47.50%	-33.20%	-29.33%	-80.60%	0.29	10.46	100.00%	-180.90%	-180.81%
RARE	ULTRAGENYX PHARMACEUTICAL INC	$1.64B	N/A	-39.70%	-66.38%	-30.60%	-4.06	1.40	82.80%	-71.70%	-72.53%
ADCT	ADC THERAPEUTICS SA	$188.49M	N/A	-28.30%	-16.34%	-28.10%	-2.03	3.05	88.60%	-95.70%	-34.22%
NTRB	NUTRIBAND INC	$74.15M	-109.00%	-95.50%	-128.89%	-1,502.60%	0.18	4.21	33.10%	-430.40%	-429.14%
FBIO	FORTRESS BIOTECH INC	$63.44M	68.50%	32.20%	54.73%	167.40%	0.65	2.93	66.20%	131.20%	162.99%
VNDA	VANDA PHARMACEUTICALS INC	$241.27M	-106.90%	-64.00%	-75.30%	-150.80%	0.91	1.54	93.60%	-119.90%	-74.67%
IFRX	INFLARX NV	$172.42M	-31.80%	-27.10%	-20.23%	-101.50%	0.12	7.26	14,418.50%	86,420.90%	86,242.58%
UTHR	UNITED THERAPEUTICS CORP	$25.18B	19.20%	17.10%	23.71%	30.10%	0.12	4.61	86.30%	38.60%	47.68%
ANAB	ANAPTYSBIO INC	$1.38B	907.00%	56.00%	1.09%	0.80%	13.75	8.40	100.00%	96.30%	1.63%
BBIO	BRIDGEBIO PHARMA INC	$15.25B	N/A	-41.70%	-43.36%	-24.80%	-2.30	2.09	94.30%	-62.60%	-54.32%
BNTX	BIONTECH SE	$21.22B	-8.00%	-7.10%	-7.64%	-16.80%	0.14	8.55	75.00%	-60.90%	-57.89%
ADRX	ADARX PHARMACEUTICALS INC	$1.58B	N/A	N/A	N/A	N/A	0.62	21.08	N/A	N/A	N/A
CYPH	CYPHERPUNK TECHNOLOGIES INC	$201.52M	-0.90%	-0.90%	0.89%	1.40%	0.03	79.19	N/A	N/A	N/A
YDES	YD BIO LTD	$345.71M	6.40%	3.80%	3.40%	10.90%	1.25	5.23	29.60%	24.70%	24.67%
AVIR	ATEA PHARMACEUTICALS INC	$345.31M	-69.90%	-61.20%	-92.25%	-119.70%	0.14	8.00	N/A	N/A	N/A
RLAY	RELAY THERAPEUTICS INC	$4.00B	-40.20%	-36.80%	-34.85%	-45.10%	0.10	14.62	100.00%	-2,837.00%	-2,837.03%
RVMD	REVOLUTION MEDICINES INC	$37.27B	-91.90%	-56.50%	-46.79%	-57.20%	0.79	8.36	99.80%	-946.80%	-906.65%
INCY	INCYTE CORP	$24.66B	7.10%	5.50%	13.65%	35.30%	0.29	3.84	92.70%	6.70%	13.29%
AGIO	AGIOS PHARMACEUTICALS INC	$1.89B	-34.60%	-32.00%	-37.90%	-36.80%	0.09	9.69	93.80%	-264.80%	-265.48%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Nov 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Xeris Biopharma Holdings (NASDAQ:XERS)

Xeris Biopharma Holdings (NASDAQ:XERS) is the #1 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Xeris Biopharma Holdings (NASDAQ:XERS) is: Value: C, Growth: A, Momentum: A, Sentiment: A, Safety: C, Financials: B, and AI: B.

Xeris Biopharma Holdings (NASDAQ:XERS) has a Due Diligence Score of 39, which is 15 points higher than the biotech industry average of 24.

XERS passed 13 out of 33 due diligence checks and has average fundamentals. Xeris Biopharma Holdings has seen its stock return 129.48% over the past year, overperforming other biotech stocks by 225 percentage points.

Xeris Biopharma Holdings has an average 1 year price target of $17.00, an upside of 2.04% from Xeris Biopharma Holdings's current stock price of $16.66.

Xeris Biopharma Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Xeris Biopharma Holdings, 20% have issued a Strong Buy rating, 60% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

Regeneron Pharmaceuticals (NASDAQ:REGN) is the #2 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Regeneron Pharmaceuticals (NASDAQ:REGN) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: B.

Regeneron Pharmaceuticals (NASDAQ:REGN) has a Due Diligence Score of 47, which is 23 points higher than the biotech industry average of 24.

REGN passed 18 out of 38 due diligence checks and has strong fundamentals. Regeneron Pharmaceuticals has seen its stock return 37.48% over the past year, overperforming other biotech stocks by 133 percentage points.

Regeneron Pharmaceuticals has an average 1 year price target of $904.29, a downside of -5.36% from Regeneron Pharmaceuticals's current stock price of $955.47.

Regeneron Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 24 analysts covering Regeneron Pharmaceuticals, 58.33% have issued a Strong Buy rating, 8.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Fennec Pharmaceuticals (NASDAQ:FENC)

Fennec Pharmaceuticals (NASDAQ:FENC) is the #3 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Fennec Pharmaceuticals (NASDAQ:FENC) is: Value: C, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Fennec Pharmaceuticals (NASDAQ:FENC) has a Due Diligence Score of 50, which is 26 points higher than the biotech industry average of 24.

FENC passed 17 out of 33 due diligence checks and has strong fundamentals. Fennec Pharmaceuticals has seen its stock return 51.11% over the past year, overperforming other biotech stocks by 147 percentage points.

Fennec Pharmaceuticals has an average 1 year price target of $16.67, an upside of 43.43% from Fennec Pharmaceuticals's current stock price of $11.62.

Fennec Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Fennec Pharmaceuticals, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 8 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Rallybio (NASDAQ:RLYB)

Rallybio (NASDAQ:RLYB) has an annual dividend yield of 86.26%, which is 73 percentage points higher than the biotech industry average of 12.82%.

Rallybio's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 6.74%, which is -6 percentage points lower than the biotech industry average of 12.82%.

Oramed Pharmaceuticals's dividend payout ratio of 7.1% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 4.45%, which is -8 percentage points lower than the biotech industry average of 12.82%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 48.3% indicates that its high dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.68% in the last day, and up 0.7% over the last week. Oragenics was the among the top losers in the biotechnology industry, dropping -42.86% yesterday.

Oragenics shares are trading lower. The stock initially rallied yesterday after the company announced it had been granted an extension to regain NYSE compliance, but it has since reversed.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 42 points higher than the biotech industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -1.55% in the past year. It has overperformed other stocks in the biotech industry by 94 percentage points.

2. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Innoviva's stock has dropped -14.28% in the past year. It has overperformed other stocks in the biotech industry by 81 percentage points.

3. Zevra Therapeutics (NASDAQ:ZVRA)

Zevra Therapeutics (NASDAQ:ZVRA) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Zevra Therapeutics has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Zevra Therapeutics's stock has dropped -1.63% in the past year. It has overperformed other stocks in the biotech industry by 94 percentage points.

Are biotech stocks a good buy now?

62.71% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 79.98% over the next year.

2.25% of biotech stocks have a Zen Rating of A (Strong Buy), 3.83% of biotech stocks are rated B (Buy), 44.82% are rated C (Hold), 36.71% are rated D (Sell), and 12.39% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 18.56x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Xeris Biopharma Holdings (NASDAQ:XERS)

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

3. Fennec Pharmaceuticals (NASDAQ:FENC)

1. Rallybio (NASDAQ:RLYB)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Zevra Therapeutics (NASDAQ:ZVRA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Xeris Biopharma Holdings (NASDAQ:XERS)

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

3. Fennec Pharmaceuticals (NASDAQ:FENC)

1. Rallybio (NASDAQ:RLYB)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Zevra Therapeutics (NASDAQ:ZVRA)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.